UCLA questionnaire may shed light on gastrointestinal burdens of systemic sclerosis

UCLA questionnaire may shed light on gastrointestinal burdens of systemic sclerosis

A questionnaire developed at the University of California, Los Angeles, can discriminate patients with systemic sclerosis who have an indication for esophago-gastro-duodenoscopy, according to data published in Arthritis Research & Therapy.However, there appears to be no association between patients’ score on the questionnaire, called the University of California, Los Angeles, Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 (UCLA GIT 2.0), with endoscopic esophagitis or pathologic findings on esophago-gastro-duodenoscopy. The researchers concluded that theRead More

Share on facebook
Share on twitter
Share on linkedin